| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.0032 | 1 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |